Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib

Hampig Raphael Kourie,1 Elie El Rassy,1 Florian Clatot,2,3 Evandro de Azambuja,4 Matteo Lambertini3,4 1Department of Oncology, Faculty of Medicine, Saint Joseph University, Beirut, Lebanon; 2Department of Medical Oncology and IRON/U1245, Centre Henri Becquerel, Rouen, France; 3Breast Cancer Transla...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kourie HR, El Rassy E, Clatot F, de Azambuja E, Lambertini M
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove Medical Press 2017-07-01
Colección:OncoTargets and Therapy
Materias:
Breast cancer
HER2-positive
neratinib
early-stage
targeted therapy.
Acceso en línea:https://www.dovepress.com/emerging-treatments-for-her2-positive-early-stage-breast-cancer-focus--peer-reviewed-article-OTT
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares